Capricor Therapeutics, Inc. (CAPR)

NASDAQ: CAPR · Real-Time Price · USD

5.19

+0.59 (12.83%)

At close: Nov 26, 2025, 4:00 PM EST

5.12

-0.07 (-1.35%)

After-hours: Nov 26, 2025, 7:59 PM EST

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2009 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2009 - 2019
Transformative Cell and Exosome-based Therapeutics	22.27M	Log In	Log In	Log In	Log In	Upgrade
Transformative Cell and Exosome-based Therapeutics Growth	-11.55%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2009 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2009 - 2019
United States	22.27M	Log In	Log In	Log In	Log In	Upgrade
United States Growth	-11.55%	Log In	Log In	Log In	Log In	Upgrade